TP53 and neoplasm: Interestingly, we found that the NEDI was highest in LUAD.2 (Fig. 2b), one of the molecular subtypes of LUAD previously defined in TCGA and known to exhibit higher tumour ploidy and mutation rates and to frequently harbour TP53 mutations [50].